ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,102 | -37.7% | 46,016 | -14.5% | 0.00% | – |
| Q2 2023 | $192,786 | -49.1% | 53,851 | -69.1% | 0.00% | – |
| Q1 2023 | $379,000 | +7685.5% | 174,122 | -57.0% | 0.00% | -100.0% |
| Q4 2022 | $4,868 | -99.7% | 404,617 | +42.2% | 0.00% | – |
| Q3 2022 | $1,844,000 | +19.7% | 284,603 | -15.4% | 0.00% | – |
| Q2 2022 | $1,541,000 | +907.2% | 336,549 | +1796.3% | 0.00% | – |
| Q1 2022 | $153,000 | -69.3% | 17,748 | -49.2% | 0.00% | – |
| Q4 2021 | $499,000 | +102.8% | 34,957 | +211.9% | 0.00% | – |
| Q3 2021 | $246,000 | +79.6% | 11,208 | +9.3% | 0.00% | – |
| Q2 2021 | $137,000 | – | 10,256 | +78792.3% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 13 | -99.6% | 0.00% | – |
| Q1 2020 | $9,000 | -40.0% | 3,000 | +76.5% | 0.00% | – |
| Q4 2017 | $15,000 | +66.7% | 1,700 | +92.1% | 0.00% | – |
| Q3 2017 | $9,000 | – | 885 | +8750.0% | 0.00% | – |
| Q2 2016 | $0 | – | 10 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,355,925 | $2,955,917 | 2.56% |
| Susquehanna International Group Ltd. | 113,526 | $247,487 | 0.14% |
| XTX Topco Ltd | 151,620 | $330,532 | 0.07% |
| Corsair Capital Management | 47,256 | $103,018 | 0.04% |
| Diametric Capital, LP | 14,314 | $31,205 | 0.02% |
| Draper Asset Management, LLC | 5,320 | $11,598 | 0.02% |
| ETF MANAGERS GROUP, LLC | 68,940 | $150,289 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $12,267 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 506,255 | $1,103,636 | 0.00% |
| Apollon Wealth Management, LLC | 20,000 | $43,600 | 0.00% |